Individual recombinant components of pyruvate and 2-oxoglutarate dehydrogenase multienzyme complexes (PDHc, OGDHc) of human and Escherichia coli (E. coli) origin were expressed and purified from E. coli with optimized protocols. The four multienzyme complexes were each reconstituted under optimal conditions at different stoichiometric ratios. Binding stoichiometries for the highest catalytic efficiency were determined from the rate of NADH generation by the complexes at physiological pH. Since some of these complexes were shown to possess 'moonlighting' activities under pathological conditions often accompanied by acidosis, activities were also determined at pH 6.3. As reactive oxygen species (ROS) generation by the E3 component of hOGDHc is a pathologically relevant feature, superoxide generation by the complexes with optimal stoichiometry was measured by the acetylated cytochrome c reduction method in both the forward and the reverse catalytic directions. Various known affectors of physiological activity and ROS production, including Ca 2+ , ADP, lipoylation status or pH, were investigated. The human complexes were also reconstituted with the most prevalent human pathological mutant of the E3 component, G194C and characterized; isolated human E3 with the G194C substitution was previously reported to have an enhanced ROS generating capacity. It is demonstrated that: i. PDHc, similarly to OGDHc, is able to generate ROS and this feature is displayed by both the E. coli and human complexes, ii. Reconstituted hPDHc generates ROS at a significantly higher rate as compared to hOGDHc in both the forward and the reverse reactions when ROS generation is calculated for unit mass of their common E3 component, iii. The E1 component or E1-E2 subcomplex generates significant amount of ROS only in hOGDHc;
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iv. Incorporation of the G194C variant of hE3, the result of a disease-causing mutation, into reconstituted hOGDHc and hPDHc indeed leads to a decreased activity of both complexes and higher ROS generation by only hOGDHc and only in its reverse reaction.
Keywords
2-oxoglutarate dehydrogenase complex; alpha-ketoglutarate dehydrogenase complex;
pyruvate dehydrogenase complex; reactive oxygen species; E3 deficiency; oxidative stress
Introduction
Pyruvate and 2-oxoglutarate(OG, also known as -ketoglutarate) dehydrogenase complexes (PDHc/OGDHc orGDHc) are central enzymes in all forms of aerobic metabolism catalyzing the oxidative decarboxylation of pyruvate and OG, respectively, generating NADH. Although the mechanisms of action and metabolic roles of these enzymes have long been established [1] [2] [3] [4] [5] [6] , they continuously regain interest due to the new pathological aspects and moonlighting activities discovered in the last decade [7] [8] [9] [10] [11] [12] [13] .
The implications of OGDHc in oxidative stress were recently reviewed [14, 15] . [3, [16] [17] [18] [19] [20] [21] [22] . The E3 component (lipoamide dehydrogenase, LADH) is common to both complexes in the same cell [23, 24] , but LADH is also part of the branched-chain keto-acid dehydrogenase complex and the glycine cleavage system [1] . There are differences among the prokaryotic and eukaryotic enzymes and also between the respective PDH and OGDH complexes in minor but functionally important additional components, the number of lipoyl domains and subunit stoichiometry (see Results and SI) [2, 3, 16, 25] , showing the versatility of these multienzyme complexes as well as the possibility of fine-tuning their function through structural assembly, in different biochemical environments.
The overall dehydrogenase reactions by PDHc or OGDHc are irreversible, although when NADH is in excess both complexes consume NADH in a reverse reaction catabolized by E3 [26] (see below).
The isolated mammalian (porcine heart) OGDHc and PDHc were shown to generate superoxide anion radical and hydrogen peroxide under pathologically relevant conditions (high NADH/NAD + ratio, acidosis) [7, 8, 27] and OGDHc was reported to serve as a major source of oxidative stress related to senescence/aging, ischemiareperfusion or neurodegeneration [7, 8, 14, 15, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . OGDHc is not only a source but also a sensitive target of reactive oxygen species (ROS) in mitochondria [5, [38] [39] [40] [41] ;
hypoxia-and glutamate-induced cerebral damage was strongly linked to the inactivation of OGDHc [34] . The mammalian PDHc was demonstrated to be a much weaker ROS generator compared to OGDHc [7, 11, 13] ; the reason for this still appears obscure [13, 36, 42] . PDHc is also sensitive to ROS, and its functional integrity is implicated to be important for neuronal longevity and survival [43, 44] . ROS generation by prokaryotic OGDHc or PDHc and its potential role have not been investigated before.
Earlier, ROS generation by OGDHc and PDHc was ascribed to the E3 flavoenzyme component (LADH) [7, 8] ; ROS generation by LADH has been addressed in several studies using isolated (mammalian) LADH or in silico approaches [26, 27, 31, 37, 42, [45] [46] [47] [48] [49] [50] . It was found that ROS production by LADH is potentiated by Zn 2+ [47] , acidosis [27] , is relevant to ischemia/reperfusion and possibly to Alzheimer's disease (for Zn 2+ ). LADH's specific disease-causing mutations [37, 42, 45, 50] [25, 27, 54, 57, 58] . Involvement of the E1-E2 sub-complexes of mammalian 2-oxoacid dehydrogenase complexes in ROS generation was speculated based upon indirect findings [27, 59 ], but could not be examined earlier in the absence of pure isolated components of the complexes.
In this study we expressed in E. coli and purified all components of both human and E. coli OGDHc and PDHc. We determined the catalytic and the superoxidegenerating activities of the reconstituted complexes under various conditions to address:
i. The optimal stoichiometry of components leading to the highest catalytic activity, ii. 
Materials and Methods

Protein Expression and Purification
The methods for overexpression and purification of E. coli E1p, 1-lip E2p and E3 components were described earlier [60] [61] [62] . Overexpression and purification of the E. coli
E1o, E2o and E3 components was also as reported earlier [63] . The human PDHc components were expressed and purified as reported in the literature (E1p [64], E2p.E3BP [65] [66] [67] , E3 [68] , and Gly194Cys E3 [37] ). The human E1o, E2o (and E3)
components were expressed and purified as reported recently [12] . Lipoyl ligase was expressed and purified as before [69] 
Reconstitution of the Multienzyme Complexes
In this paper, for the purpose of enzymatic activity measurement, the mass ratio (g: g: g) of the individual components assembled into complexes was applied rather than the molar ratio of their subunits (M: M: M), both of which have been reported in the literature. Generally, the mass ratio (g: g: g) of 1:1:1 was tested first and then conditions of component assembly were optimized for each complex individually, taking into account the subunit stoichiometry reported in the literature (see Supporting
Information for reconstitution of each individual complex and the corresponding Figure   Legends ). superoxide (detected by cyt c). Superoxide detection was initiated by the addition of 2 mM pyruvate or 2 mM 2-oxoglutarate (10 L, 5% of the volume) due to the higher volume (generally 40 L) of the protein complexes needed because of the low sensitivity of the cyt c assay. The initial reaction velocity was measured and converted to the amount of the superoxide generated per unit time per mg protein, taking into account a 1:1 stoichiometry of the reaction between cyt c and superoxide [80] . Statistics. Statistical differences were evaluated in Excel with two-tailed Student's t-tests assuming unequal variances and were accepted to be significant when P < 0.05.
Measurement of Enzyme
Superoxide detection in the non
Results
Superoxide production by E. coli pyruvate and 2-oxoglutarate dehydrogenase complexes.
Superoxide production by E. coli PDHc and its components. As displayed in Fig. 1 Fig. S1 ; the latter mass ratio was calculated using a molar ratio of subunits and mass of subunits from the literature -see SI), and superoxide production could be considered as a side reaction (0.12% at 3.98:2.72:1 mass ratio of E1p:E2p:E3 components). As is also evident from Fig. 1 , the E1p on its own and the corresponding E1p-E2p sub-complex do not produce any significant amount of superoxide, suggesting that E3 is responsible for superoxide production in both the forward and the reverse (non-physiological) reactions, as expected from earlier reports [7, 8, 27] . It is well accepted that E3 catalyzes the transfer of reducing equivalents from dihydrolipoamide (covalently amidated onto E2) to NAD + in the physiological direction via FAD and a disulfide redox center on E3, resulting in lipoamide-E2 and NADH. In the reverse direction, NADH reduces FAD and the disulfide exchange site on E3 which with oxygen first leads to superoxide and then to H 2 O 2 by dismutation of the former [48, 85] . Generation of radical species by flavoenzymes, including dihydrolipoamide dehydrogenase, is well-established [7, 8, 27, 37, [47] [48] [49] 86] .
As expected, the E3 component by itself also produced superoxide [27, 37] in the reverse direction, as indeed could the assembled PDHc (Fig, 1 , bars 2 and 4). This rules out the need for E2p in ROS production, rather it implicates the two proximal cysteines in E3, known to undergo reversible oxidation-reduction and assisting in the formation of a redox couple with FAD, and FAD itself (see above). [37] . The data above clearly indicate that hE3 assembled into hPDHc could produce superoxide with efficiency similar to that of the isolated hE3. Since no superoxide generation was detected with either hE1p or hE1p-hE2.E3BP sub-complex in the absence of hE3 (data not shown), the superoxide generation by hPDHc in the physiological direction could be attributed to hE3.
Superoxide generation by isolated G194C hE3 was about two-fold higher than that for wt hE3 (191.6 nmol· min -1 ·mg E3 -1 , not shown in figure) and was in accordance with data reported from the Adam-Vizi laboratory earlier [37] . Next, the G194C substituted hE3 was reconstituted with hE1p and hE2p.E3BP sub-complex. In the forward physiological direction this hPDHc displayed lower superoxide activity (Fig. 3) (42.5 nmol· min -1 ·mg E3 -1 ) as compared with superoxide activity of 56.7 nmol· min -1 ·mg E3 -1 detected for hPDHc reconstituted with wt E3 (compare bars 2 and 4 in Fig. 3 ).
However, there was no statistically significant difference between the rates of superoxide production in the reverse direction (compare bars 3 and 5 in Fig. 3 ).
The superoxide generating activity of the complex reconstituted with the G194C variant of hE3 measured in the reverse non-physiological direction was also similar in magnitude to that of the uncomplexed hE3 (bars 1 and 5 in Fig. 3) .
Superoxide generation by hOGDHc. On reconstitution of hOGDHc from hE1o, hE2o, and hE3 components with a mass ratio of 4.30:1.68:1, an overall NADH producing activity of 0.625 mol·min -1 ·mg E3 -1 was detected at maximum efficiency (Fig. S4 ).
Similarly to the E. coli complexes and to hPDHc, the hOGDHc was effective in generating superoxide with an activity of 12.1 nmol ·min -1 ·mg E3 -1 in the forward physiological direction (1.9% of the overall OGDHc reaction of NADH production) and 40.5 nmol· min -1 · mg E3 -1 in the reverse reaction (Fig. 4) , again significantly higher than in the forward physiological direction (compare bars 2 and 1 in Fig. 4 ).
What distinguishes hOGDHc from the other complexes discussed, is that the hE1o and hE1o-hE2o sub-complex, even in the absence of hE3, were still able to generate superoxide in the forward physiological direction with the following rates: 2.06 nmol· min -1 ·mg E1o -1 for hE1o on its own and 1.76 nmol· min -1 ·mg E1o -1 for the hE1o-hE2o sub-complex (bars 5 and 6 in Fig.4) . The results suggest that hE2o may not contribute to superoxide generation. It had been suggested for porcine heart OGDHc [27, 88] that superoxide could also be generated by E2o via a thiyl radical in the absence of E3, but our results provide still no clear evidence for this [59] .
As was reported by our groups, the ThDP-enamine radical could be detected by EPR using hE1o by itself, or hE1o assembled into hOGDHc. The concentration of ThDP-enamine radical was 0.9 M for hE1o (0.2% occupancy of active centers) and 1.3 M for hE1o assembled into hOGDHc (0.59% occupancy of active centers) [12] . The data here reported clearly demonstrate first the important difference between hOGDHc and hPDHc, and second between human and prokaryotic OGDHc complexes. The ThDPenamine radical is the likely source of superoxide on free hE1o, while ROS generation by the intact OGDHc was ascribed to the E3 component [7, 8] . Reconstitution of the human OGDHc with Gly194Cys substituted E3 (result of a pathogenic mutation) resulted in a statistically significant (21.5%) decrease in superoxide generation in the forward physiological direction (compare bar 3 versus bar 1 in Fig. 4) , whereas in the reverse E3 reaction a (statistically significant) 11.3% increase was observed upon this diseasecausing amino acid substitution (compare bars 4 and 2 in Fig. 4 ). This is the first study to demonstrate that ecPDHc and ecOGDHc could produce superoxide. Given the similar observations made earlier with mammalian enzymes [7, 8, 27] , it can now be stated that 2-oxo acid dehydrogenase complexes, in general, possess the ability of ROS generation, in particular, under pathologically relevant conditions (acidosis, high NADH/NAD + ratio and/or when the physiological e --acceptor is absent or present only at small concentrations). Given that E3 is likely the primary site for ROS production by the intact complexes [7, 8] , and that ecE3 and hE3 show a high degree of sequence similarity (44% identity), this generalized concept always seemed reasonable, but had not been experimentally investigated or proven before. The results for the prokaryotic enzymes show that ecPDHc is just as much, if not more efficient as a superoxide producer as ecOGDHc in vitro. Obviously, substrate and cofactor availability under physiological or pathological conditions may modulate these catalytic efficiencies and their ratios in vivo [13] . We also found that both prokaryotic complexes generate more superoxide in the reverse than in the forward reactions, similarly to the eukaryotic enzymes, implying that the mechanisms are likely similar. Neither prokaryotic subcomplexes (ecE1p/o, ecE1p/o-ecE2p/o) exhibited detectable superoxide generating activity under our assay conditions, which, in the case of ecOGDHc is a marked difference relative to the eukaryotic enzyme. The fact that the prokaryotic 2-oxo acid dehydrogenase complexes are also able to generate ROS implies that this feature remained an inherent property of these enzymes throughout evolution. This highly conserved mechanism may have similar implications in prokaryotes to the ones in eukaryotes, such as self-regulation (e.g., for metabolic enzymes such as OGDHc [88] ), signal transduction (e.g., regulation by transcription factors [36, 89, 93] ), or defense (e.g., by cytotoxic lymphocytes in mammals [94] ). Obviously, over-production of ROS may lead to cellular damage in any organism or tissue [28-30, 36, 95] .
Discussion
ROS generation by hOGDHc is heavily implicated in the progression
In the human brain, the activity of OGDHc is a rate-limiting step in the Krebs cycle [1, 2, 4, 5, 76, 96] and the activity of hPDHc was found to be five-fold higher than that of hOGDHc [97] . This ratio was ~3 (mitochondrion) or ~7 (intact cell) in fibroblasts and ~1.5 (mitochondrion) or ~15 (intact cell) in leukocytes [98] . In alamethicin permeabilized rat brain mitochondria the activities of the two enzymes were nearly identical [7] . Measurements with the reconstituted human enzymes in our study demonstrate that hPDHc (37 unit/mg E3) was ~59 times more active than hOGDHc (0.625 unit/mg E3). Superoxide activity in the forward reaction was ~ 5-fold higher for hPDHc than hOGDHc, whereas in the reverse reaction hPDHc generated superoxide at a ~2.5-fold higher rate as compared to hOGDHc when this activity was calculated for the unit amount of their common E3 subunit. The higher physiological activity of hPDHc (relative to that of hOGDHc) is in accord with literature data (see above). The higher (both forward and reverse reactions) superoxide generating capacities of hPDHc relative to those of hOGDHc also applies to the prokaryotic complexes in this study, but not to the isolated porcine equivalents studied earlier [7, 8] , which Sigma preparations however proved to be of questionable purities in our hands. In a broader sense, we propose that potentially all 2-oxo acid dehydrogenase complexes should be considered as potent ROS generating enzymes, although in vivo conditions and their transcriptionally/translationally determined total amounts may considerably modulate their efficiency to contribute to the gross ROS production of mitochondria or cells [13] .
Complex I isolated from bovine heart mitochondria produced 42.1 nmol. [103] .
The fact that the uncomplexed hE1o, as well as the hE1o-hE2o sub-complex could generate superoxide in the forward reaction comparable to that generated by hOGDHc, is of particular interest. This is a marked difference from what we found with the other three complexes, which exhibited no measurable superoxide generation when lacking the respective E2/E3 or just the E3 components. Plausible mechanistic explanation for the above observation concerning hE1o were suggested in our recent study [12] , suggesting differences in the stabilities of respective ThDP-bound postdecarboxylation catalytic intermediates on hOGDHc and hPDHc (Scheme 1). ROS (superoxide and H 2 O 2 ) generation by hE1o, first reported recently [12] , might have pathological relevance under conditions where the stoichiometric assembly of the hOGDHc is compromised and hE1o is present in excess inside mitochondria [21, [111] [112] [113] [114] [115] . Earlier, it was concluded that for ROS generation by the mammalian OGDHc, the E3 component was solely responsible [7, 8] . As the E1o-E2o subcomplex is far more stable than the (E1o-E2o)-E3 complex for OGDHc [54] [55] [56] , the above condition may result from genetic deficiencies of hE2o (for further discussion, see [12] ). ROS generation by the hE1o-hE2o subcomplex may have potential relevance (under certain pathological conditions), as E3 binds ~30 times less tightly to OGDHc than to PDHc [54] [55] [56] , and this may be more pronounced in acidosis [27] . We propose that in acidosis, uncomplexed E3 in the reverse reaction, as well as the E1o-E2o subcomplex in the forward reaction might generate ROS, provided that sufficiently high concentrations of NADH or OG, respectively are available. This new mechanistic view may be worth considering in targeting ROS generation by OGDHc, but additional investigations are needed to further characterize ROS generation by this subcomplex. Scheme 1 provides a summary of the known sites of superoxide generation on the hOGDHc subcomplexes and the fully assembled 2-oxoacid dehydrogenase complexes in general according to the current literature [12, 47, 48, 85] .
Since the G194C pathogenic amino acid substitution of hE3 [116] [117] [118] is usually accompanied by lactic acidosis, it was important to address the activity of hPDHc with this substitution at pH 6.3. This pathogenic substitution led to an 87% decrease in the overall assay (see SI and Fig. S3 , bars 4 and 7), in good agreement with the 80-90% loss of hPDHc activity found in patients with either heterozygote or homozygote mutations [84, 116, 118] . The activity of hOGDHc similarly diminishes under conditions in vitro when the complex is reconstituted with the G194C hE3 (SI Fig. S4 ). It is also important to emphasize that the isolated hE3 G194C did not display significant loss of activity either in the forward or the reverse reaction, but showed a significantly enhanced superoxide generation in the reverse reaction [37] . An elucidation of the mechanism by which hE3 with the G194C substitution decreases the overall PDHc and OGDHc activities will be the subject of further investigations. There are a few pathogenic mutations of hE3 that impede the recruitment of hE3 to hE3BP (in hPDHc) [119] ; this may also occur with hE3 G194C thus offering a plausible explanation for the above findings. It is noteworthy that the presence of hE3 G194C lowered superoxide generation in the forward direction for both complexes to a similar extent (~20%), pointing to a potentially similar mechanism. In the reverse reaction it did not alter superoxide generation by hPDHc, whereas it significantly (~11%) increased superoxide production by hOGDHc; the augmented ROS production by hOGDHc containing hE3 G194C may also contribute to the cellular/tissue damage associated with this mutation. These results complement a previous report on isolated hE3 G194C [37] , which showed significantly enhanced (>70%) ROS generation due to this substitution.
It is clear from the present results that the G194C hE3 substitution substantially reduces, by a hitherto unelucidated mechanism, primarily the activity of PDHc, but also that of OGDHc, while its own catalytic activity is essentially unchanged [37] , and results in an excess ROS generation in the reverse reaction by hOGDHc. However, hE3 G194C
generates ROS at an even higher rate when it is present uncomplexed [27, 57, 58] .
The present findings add to our understanding of the molecular pathology of 2-oxo acid dehydrogenase complexes in general, and to that of hPDHc and hOGDHc in particular, with both complexes being potentially involved in the mechanisms of neurodegenerative diseases.
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